Prof Adam Taylor, from Lancaster University, said potential benefits in pre-clinical studies such as those in animals and cells do not necessarily mean a peptide is beneficial for humans
Verify that the actuator releases 0.10 mL per full stroke before applying the main table
On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
DSIP, short for Delta Sleep Inducing Peptide, is a research peptide commonly studied for its potential role in sleep-related pathways, neuropeptide activity, and circadian rhythm regulation
BPC-157 research focuses on angiogenesis and growth-factor pathways and includes a broad gastrointestinal record, while TB-500 research focuses on actin regulation and cell migration
I've been to their forum a few times & his asnwers to questions are short & rude IMHO